Response to A Korean Post-Marketing Study of Abacavir/Dolutegravir/ Lamivudine in Patients with HIV-1
- Author:
Sudip BHATTACHARYA
1
;
Sandip BHATTACHARYA
Author Information
- Publication Type:Correspondence
- From:Infection and Chemotherapy 2024;56(1):96-97
- CountryRepublic of Korea
- Language:EN
